Contracts Finder · Award

RA225400 - laprosurg

A public procurement published by University College of London Hospitals NHS Foundation Trust via Contracts Finder.

Contracts FinderAward
£150
Award value
Tender value
1
Suppliers
1
Awards
1
Notices
Award
Stage

Overview

To access this competition: login to https://suppliers.multiquote.com and view the opportunity RA225400. Not registered on MultiQuote - visit https://suppliers.multiquote.com then register and quote RA225400 as the reason for registration. Any queries please contact MultiQuote on 0151 482 9230.

Key details

Source
Contracts Finder
Lifecycle stage
Award
Status
complete
CPV classification
33000000 — Medical equipments, pharmaceuticals and personal care products
Currency
GBP
Total award value
£150
Tender value
First published
8 Sept 2017
Last updated
8 Sept 2017
View the original notice

Awards

1 award recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
Laprosurge Ltd020464707 Sept 2017active£150

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Award noticeRA225400 - laprosurg

All suppliers

Frameworks & programmes

More from University College of London Hospitals NHS Foundation Trust

FAQs about this procurement

Who is the buyer for "RA225400 - laprosurg"?

RA225400 - laprosurg is a UK public-sector procurement published by University College of London Hospitals NHS Foundation Trust via Contracts Finder.

Has "RA225400 - laprosurg" been awarded?

Yes — 1 award is recorded, with a reported total value of £150. The current lifecycle stage is "Award".

Which suppliers are involved in "RA225400 - laprosurg"?

1 supplier is linked: Laprosurge Ltd.

What is "RA225400 - laprosurg" worth?

The reported award value is £150.

When was "RA225400 - laprosurg" published?

It was first published on 8 Sept 2017 and last updated on 8 Sept 2017, across 1 notice.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable